gLIMS Business Transformation Analyst jobs in United States
cer-icon
Apply on Employer Site
company-logo

Lonza · 12 hours ago

gLIMS Business Transformation Analyst

positionUS - Bend, OR
timeFull-time
remoteOnsite
seniorityMid Level
date3+ years exp

Lonza is a global leader in life sciences operating across five continents. This role offers an exciting opportunity to lead digital transformation within our Quality Control team, enhancing global laboratory information systems.

BiotechnologyLife SciencePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Translate user requirements into practical system solutions with external integrators
Conduct informal testing to verify functionality before formal validation
Support IT and QA teams to deliver high-quality documentation on time
Evaluate Phase 2 requirements to reduce complexity and favor process improvements
Provide and execute test cases for system interfaces like MES, SAP, and CDS
Align cross-functional stakeholders for smooth system integration
Run business test cases and escalate critical issues when needed

Qualification

Quality Control processesGMPCSVProject managementEffective communication

Required

Bachelor's degree in Chemistry or a related scientific field, or equivalent experience
Around three years of experience in a similar role; advanced degrees may substitute experience
Strong knowledge of Quality Control processes and global standards
Basic project management skills including timelines and deliverables
Familiarity with GMP and CSV to ensure compliance
Ability to communicate effectively across technical and business teams

Benefits

Medical, dental and vision insurance.
Access to our full list of global benefits at https://www.lonza.com/careers/benefits.

Company

Lonza

twittertwittertwitter
Glassdoor3.6
company-logo
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
dateFounded in 1897
location
Basel, Basel-Stadt, CHE
people-size10001+ employees
web-link
http://www.lonza.com

H1B Sponsorship

Lonza has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)

Funding

Current Stage
Public Company
Total Funding
$444.8M
2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO

Leadership Team

leader-logo
Wolfgang Wienand
Chief Executive Officer
linkedin
leader-logo
Alfons Ehinger
Founder

Recent News

NH Business Review
2026 BOB Award winners
2026-01-17
GlobeNewswire
Exosome Research Market Projected to Reach US$ 2,491.42 Million by 2035, Supported by Expanding Therapeutic Development Pipelines | Astute Analytica
2026-01-15
PR Newswire
Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs
2026-01-07
Company data provided by crunchbase